Clinical Trials Browser

Terminated × figitumumab × Clear all

NCT00872404 2016-04-20

A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Phase 2 Terminated

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT00372996 2015-10-28

Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer

Phase 2 Terminated

219 enrolled 11 charts

Breast Neoplasms

NCT00729833 2014-06-09

Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors

Phase 1 Terminated

45 enrolled 18 charts

Other solid neoplasm

Advanced Cancer

NCT00596830 2014-01-13

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Phase 3 Terminated

681 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Adenosquamous, Carcinoma, Large Cell

NCT00976508 2013-12-13

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Phase 1 Terminated

24 enrolled 10 charts

BreastGastrointestinalGenitourinarySarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT00673049 2013-07-24

NSCLC

Phase 3 Terminated

583 enrolled 11 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00977561 2013-02-25

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

9 enrolled 7 charts

Small Cell Lung Carcinoma